In the last trading session, 1.54 million TransCode Therapeutics Inc (NASDAQ:RNAZ) shares changed hands as the company’s beta touched 1.35. With the company’s per share price at $0.44 changed hands at -$0.02 or -2.88% during last session, the market valuation stood at $10.39M. RNAZ’s last price was a discount, traded about -14975.0% off its 52-week high of $66.33. The share price had its 52-week low at $0.38, which suggests the last value was 13.64% up since then. When we look at TransCode Therapeutics Inc’s average trading volume, we note the 10-day average is 6.3 million shares, with the 3-month average coming to 7.23 million.
TransCode Therapeutics Inc (NASDAQ:RNAZ) trade information
Instantly RNAZ was in red as seen at the end of in last trading. With action -10.10%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -86.80%, with the 5-day performance at -10.10% in the red. However, in the 30-day time frame, TransCode Therapeutics Inc (NASDAQ:RNAZ) is -71.66% down. Looking at the short shares, we see there were 0.34 million shares sold at short interest cover period of 0.15 days.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 300k. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -28.81%. The 2025 estimates are for TransCode Therapeutics Inc earnings to increase by 8.19%.
RNAZ Dividends
TransCode Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Nov-13.
TransCode Therapeutics Inc (NASDAQ:RNAZ)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.15% of TransCode Therapeutics Inc shares while 0.67% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 0.67%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund . With 2.81 shares estimated at $1252.0 under it, the former controlled 0.02% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Total Market Index Fund held about 0.01% of the shares, roughly 1.18 shares worth around $524.0.
